Previous 10 | Next 10 |
2023-12-14 13:51:23 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ImmunoPrecise Antibodies (NASDAQ: IPA ) just reported results for the second quarter of 2024. ImmunoPrecise Antibodies reported earnings per share of -7.4 cents. This was ...
2023-12-14 12:49:18 ET More on ImmunoPrecise ImmunoPrecise Antibodies Ltd. (IPA) Q2 2024 Earnings Call Transcript ImmunoPrecise Antibodies appoints Mitch Levine as Chairman of Board Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data...
2023-12-14 12:40:22 ET ImmunoPrecise Antibodies Ltd. (IPA) Q2 2024 Earnings Conference Call December 14, 2023 10:30 AM ET Company Participants Jennifer Bath - President and Chief Executive Officer Kristin Taylor - Chief Financial Officer Conference Call Partici...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for its second quarter of the 2024 fiscal year (“FY24”), which e...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), today announced the closing of its $1.265 million underwritten public offering of 1,265,000 common shares, including 165,000 common shares issued pursuant to the full...
2023-12-07 09:45:34 ET More on ImmunoPrecise ImmunoPrecise Antibodies Ltd. (IPA) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data for ImmunoPrecise Financial information for ImmunoPrecise F...
VICTORIA, BC / ACCESSWIRE / December 7, 2023 / ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming financial reporting activities. At its recent Annua...
2023-12-06 12:41:58 ET More on Mid-day movers $ stocks. Altimmune: Don't Buy The GLP-1 Move-Up Altimmune: Pemvidutide Data Reinforces Obesity Drug Outlook Syros Pharmaceuticals, Inc. (SYRS) Q3 2023 Earnings Call Transcript Altimmune weight-loss drug performed...
2023-12-06 08:38:42 ET More on pre-market losers and stocks. NeuroSense: A Hold Ahead Of Phase 2b ALS Data NeuroSense ALS candidate meets key study goals Janover inks strategic referral partnership with La Rosa Holdings Seeking Alpha’s Quant Rating on ...
2023-12-06 07:12:04 ET More on ImmunoPrecise ImmunoPrecise Antibodies Ltd. (IPA) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on ImmunoPrecise Historical earnings data for ImmunoPrecise Financial information for ImmunoPrecise F...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPA Stock Symbol:
NASDAQ Market:
VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already successful LENS ai TM Platform. LENS ai , which is run by the company's subsidiary, BioStran...
VICTORIA, BC / ACCESSWIRE/ April 12, 2024 / InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability and speed challenges partnered with ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), an artificial intelligence-dri...
Immunoprecise Antibodies Ltd (NASDAQ:IPA), together with InterSystems, have collaborated to integrate the new vector search capability of the Int...